{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T03:16:17Z","timestamp":1776827777828,"version":"3.51.2"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.ejca.2011.11.016","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T20:54:01Z","timestamp":1323723241000},"page":"492-500","source":"Crossref","is-referenced-by-count":40,"title":["Venous thromboembolism (VTE) in patients with advanced gastric cancer: An Asian experience"],"prefix":"10.1016","volume":"48","author":[{"given":"Myoung Joo","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baek-Yeol","family":"Ryoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Hee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Hoe","family":"Koo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heung Moon","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Lyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Koo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejca.2011.11.016_b0005","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ejca.2011.11.016_b0010","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.ejca.2011.11.016_b0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejca.2011.11.016_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","article-title":"Incidence of venous thromboembolism in patients hospitalized with cancer","volume":"119","author":"Stein","year":"2006","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ejca.2011.11.016_b0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ejca.2011.11.016_b0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"25","key":"10.1016\/j.ejca.2011.11.016_b0035","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM200012213432504","article-title":"Prognosis of cancers associated with venous thromboembolism","volume":"343","author":"S\u00f8rensen","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejca.2011.11.016_b0040","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau\u2019s syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ejca.2011.11.016_b0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1470-2045(05)70207-2","article-title":"Cancer and venous thromboembolism","volume":"6","author":"Prandoni","year":"2005","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2011.11.016_b0050","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJMra0801082","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ejca.2011.11.016_b0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ejca.2011.11.016_b0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2011.11.016_b0065","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.ejca.2011.11.016_b0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"issue":"16S","key":"10.1016\/j.ejca.2011.11.016_b0075","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/jco.2005.23.16_suppl.4003","article-title":"Randomized phase 3 trial of irinotecan (CPT-11)+5FU\/folinic acid (FA) vs CDDP+5FU in 1st-line advanced gastric cancer patients","volume":"23","author":"Dank","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2011.11.016_b0080","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1442-2050.2008.00829.x","article-title":"Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction","volume":"21","author":"Tetzlaff","year":"2008","journal-title":"Dis Esophagus"},{"issue":"31","key":"10.1016\/j.ejca.2011.11.016_b0085","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2011.11.016_b0090","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1538-7836.2009.03731.x","article-title":"The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer","volume":"8","author":"Lee","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.ejca.2011.11.016_b0095","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1002\/cncr.22626","article-title":"The impact on survival of thromboembolic phenomena occurring before and during protocol chemotherapy in patients with advanced gastroesophageal adenocarcinoma","volume":"109","author":"Tetzlaff","year":"2007","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ejca.2011.11.016_b0100","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1200\/JCO.2008.19.4274","article-title":"Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Group","volume":"27","author":"Starling","year":"2009","journal-title":"J Clin Oncol"},{"issue":"23 Suppl. 1","key":"10.1016\/j.ejca.2011.11.016_b0105","first-page":"I4","article-title":"The epidemiology of venous thromboembolism","volume":"107","author":"White","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ejca.2011.11.016_b0110","doi-asserted-by":"crossref","first-page":"737","DOI":"10.7326\/0003-4819-128-9-199805010-00006","article-title":"Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California","volume":"128","author":"White","year":"1998","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ejca.2011.11.016_b0115","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0002-9149(00)00766-9","article-title":"Risk of pulmonary embolism and\/or deep venous thrombosis in Asian-Americans","volume":"85","author":"Klatsky","year":"2000","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.ejca.2011.11.016_b0120","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jama.1997.03540400055031","article-title":"Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening","volume":"277","author":"Ridker","year":"1997","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ejca.2011.11.016_b0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J","article-title":"Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations","volume":"73","author":"Gregg","year":"1997","journal-title":"Am J Med Genet"},{"issue":"23 Suppl. 1","key":"10.1016\/j.ejca.2011.11.016_b0130","first-page":"I17","article-title":"Venous thromboembolism and cancer: risks and outcomes","volume":"107","author":"Lee","year":"2003","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.ejca.2011.11.016_b0135","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1200\/JCO.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2011.11.016_b0140","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/10428190600560991","article-title":"Venous thromboembolism in patients with diffuse large B-cell lymphoma","volume":"47","author":"Komrokji","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.ejca.2011.11.016_b0145","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdm284","article-title":"Venous thromboembolism predicts poor prognosis in irresectable pancreatic cancer patients","volume":"18","author":"Mandal\u00e0","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2011.11.016_b0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1613051","article-title":"Venous thrombosis in patients with solid tumors: determination of frequency and characteristics","volume":"87","author":"Sallah","year":"2002","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.ejca.2011.11.016_b0155","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/cncr.20893","article-title":"Prospective evaluation of major vascular events in patients with nonsmall cell lung carcinoma treated with cisplatin and gemcitabine","volume":"103","author":"Numico","year":"2005","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2011.11.016_b0160","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","article-title":"Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"26","author":"Al-Batran","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491100935X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491100935X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T16:57:21Z","timestamp":1561049841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491100935X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S095980491100935X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2011.11.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}